Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 65%
filed 2026-06-08
Item 7.01
The filing discloses a press release providing an update on a "previously announced process to evaluate strategic alternatives" for the registrant. This language suggests ongoing M&A or restructuring activity, but the Item 7.01 disclosure is vague and does not specify the nature, status, or outcome of the strategic review. Without access to the attached press release (Exhibit 99.1), the precise event type cannot be determined; however, strategic alternatives processes typically involve potential M&A, divestitures, or going-concern considerations that would be material to investors. Classified as other_material pending review of the exhibit.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
The filing discloses entry into a material secured loan agreement (Item 1.01) with Agile Capital Funding, LLC on May 27, 2026, for approximately $260,000 borrowed with ~$389,740 total due over 32 weeks. While this creates a direct financial obligation (Item 2.03), it does not fit cleanly into the covenant_breach category (no breach alleged) or dilutive_issuance (debt, not equity). The subordinated nature and short repayment term suggest financial stress, but the event is best classified as a material financing arrangement outside the standard taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Tonix announced entry into an agreement with a group purchasing organization (GPO) providing coverage for TONMYA® to approximately 17 million U.S. commercially insured individuals, effective June 1, 2026. This represents a significant commercial milestone for the company's product, expanding market access beyond the ~75 million Medicaid beneficiaries already covered. While this is a material commercial development affecting the company's market opportunity and competitive position, it does not fit neatly into the standard 8-K event taxonomy (not M&A, not an executive change, not a financial restatement or impairment), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 7.01
The Company disclosed that the DOE reinstated a Grant and extended the project and budget periods. This represents a material positive development for a battery technology company — reinstatement of federal funding and project extension would affect investor assessment of the company's financial resources and operational runway. However, the Item 7.01 disclosure is deliberately non-specific about the grant amount, original terms, or financial impact, and the actual press release content is not provided in the excerpt. Without those details, the event does not fit cleanly into earnings_release, ma_activity, or other more specific categories, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 1.02
Celcuity completed a voluntary prepayment of approximately $137.5 million to fully satisfy and discharge its Amended and Restated Loan and Security Agreement with Oxford Finance and Innovatus Life Sciences, terminating all obligations under the facility and eliminating associated debt covenants.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
The filing discloses a 1-for-5 reverse stock split effectuated via Certificate of Change filed June 2, 2026, becoming effective June 11, 2026. While reverse stock splits are structural corporate actions, this one is material to investors as it reduces outstanding shares from ~365 million to ~73 million and affects trading mechanics, stock option/RSU adjustments, and fractional share treatment. The event does not fit neatly into the specific taxonomy categories (not a bylaw amendment alone, not M&A, not an impairment), making "other_material" the most appropriate classification for this significant capital structure modification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 5.03
The company changed its corporate name from Brilliant N.E.V. Corp. to Origin Tea Inc. and implemented a 1-for-8 reverse stock split, both approved by the Board and stockholders and filed with the Nevada Secretary of State on June 7, 2026. The reverse stock split proportionately reduces authorized shares from 345 million to 43.125 million and materially affects share count and trading mechanics.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
The Board approved a material strategic pivot to the tea industry, including incorporation of foreign subsidiaries (Origin Tea Industry Limited in Hong Kong and a wholly foreign-owned enterprise in China), relocation of principal executive offices to Hainan, and authorization of a private placement financing program. The company remains a shell company with no securities yet issued under the financing program.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The disclosure concerns the conversion price of subordinated convertible notes due 2031, which affects the terms and potential dilution of an outstanding debt instrument. While the specific content is not provided, conversion price adjustments or resets on convertible securities are material to investors assessing capital structure and dilution risk, but do not fit neatly into the more specific event categories (not a new issuance under dilutive_issuance, not a covenant breach, and not exec/M&A activity). This is classified as other_material given its disclosure under Item 8.01 and relevance to the company's financial obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
Strive announced a bitcoin purchase of 32 BTC at ~$63,911 per coin during June 2-7, 2026, along with updates to its treasury holdings (cash, bitcoin, and STRC Stock positions) and share counts. While this reflects the company's ongoing bitcoin treasury strategy, the disclosure does not fit neatly into standard 8-K event categories. The purchase and treasury updates are material to investors assessing the company's asset composition and capital allocation, but the event is primarily an operational/treasury update rather than a discrete corporate action (M&A, impairment, covenant breach, etc.). Classified as other_material because it is a material treasury/asset activity that does not align with more specific event types.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 8.01
The disclosure announces a monthly common dividend of $0.08 per share declared by the Board of Trustees, payable July 31, 2026. While dividend declarations are routine for REITs and BDCs like Ellington Credit, this is material to investors as it affects shareholder returns and capital allocation. However, it does not fit neatly into the more specific event categories (not earnings, not executive action, not M&A, etc.), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 7.01
This Item 7.01 disclosure is a business update providing portfolio performance metrics, capital inflows, and liquidity position for TPG Twin Brook Capital Income Fund. While it includes material operational information (9.8% annualized returns since inception, $4.5 billion portfolio, $181 million capital inflows, $832 million liquidity), it does not fit neatly into the specific event categories. The disclosure is a periodic business update rather than a discrete material event like M&A, executive changes, restatement, or covenant breach. It is material to investors assessing fund performance and financial health, but lacks the triggering event character of the more specific categories.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The Board authorized a share repurchase program for up to 1,000,000 shares funded by subsidiary dividends, with authority to enter Rule 10b5-1 trading plans. While share repurchases are capital allocation decisions material to investors, this disclosure does not fit the more specific event categories (not an earnings release, executive change, M&A, impairment, or covenant breach). The authorization itself—distinct from actual repurchases—is a material corporate action affecting shareholder value and capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 1.01
This disclosure describes a material definitive agreement for share repurchase from a related party (Magnus Holdings Co., Ltd.) for up to $52.5 million under the Company's existing $1.25 billion repurchase authorization. While share repurchases are routine capital allocation activities, this transaction involves a related-party component and structured pricing mechanics that distinguish it from standard open-market buybacks. The agreement does not constitute a traditional M&A activity, dilutive issuance, or other enumerated event type, making "other_material" the most appropriate classification for this related-party share purchase arrangement.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The Board authorized a stock repurchase program for up to $100 million over 36 months, effective June 3, 2026, replacing the prior 2023 program. This capital allocation decision is material to investors but does not fit the more specific event taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 8.01
This disclosure reports the completion of FortuneX's IPO on May 26, 2026 (7.5M units at $10/unit for $75M gross proceeds), the full exercise of the underwriters' over-allotment option on May 29, 2026 (1.125M additional units for $11.25M), and a concurrent private placement to the Sponsor (15,000 units for $150K). While the IPO itself is a capital-raising event material to investors, the Item 8.01 framing and the absence of a formal earnings release or press release exhibit suggest this is a post-closing confirmation rather than an earnings_release. The event is material (total gross proceeds ~$86.4M) but does not fit neatly into the more specific categories; it is best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 7.01
Vivakor announced entry into a significant recurring crude oil transaction covering 100,000 barrels per month, representing approximately $108 million in annualized revenue. This material commercial arrangement affects investor assessment of the company's revenue prospects and business operations.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 7.01
Haemonetics announced a material restructuring of its reportable segment structure, combining Plasma and Blood Center into a single "Apheresis" segment and renaming Hospital to "MedSurg," effective Q1 FY2027. This change affects how investors will receive and analyze financial information going forward, including recast historical data and guidance. While segment reorganizations are administrative in nature, this disclosure materially impacts the transparency and comparability of financial reporting, making it material to investors' assessment of the company's business performance and structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 7.01
Hallador Energy announced that its subsidiary was selected by the U.S. Department of Energy to begin award negotiations for up to $27.2 million in federal funding to modernize the Merom Generating Station. This represents a material development—a significant potential capital infusion and government recognition—but does not fit neatly into the standard taxonomy categories (not M&A, not an executive change, not a restatement or impairment). The funding is conditional ("potential" and "award negotiations"), making it distinct from a completed transaction, but the scale and strategic importance to a coal-focused energy company warrant material classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
Hut 8 Corp. announced the pricing of a $4.25 billion senior secured debt offering by its subsidiary Beacon Point DC LLC. While this is a material financing event that would affect investor assessment of the company's capital structure and liquidity, it does not fit cleanly into the standard taxonomy categories (not an earnings release, M&A activity, impairment, or other specifically enumerated event types). The disclosure is material because a $4.25 billion debt issuance significantly impacts the registrant's financial position and obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 8.01
Duke Energy Carolinas consummated the issuance and sale of $2.4 billion in mortgage bonds across three series (4.65% due 2031, 5.15% due 2036, and 5.75% due 2056) on June 5, 2026. While this is a material debt financing event affecting the company's capital structure and financial position, it does not fit cleanly into the standard 8-K taxonomy categories. The disclosure is a straightforward debt issuance completion rather than a restatement, impairment, covenant breach, or other more specific event type, warranting classification as "other_material."
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
The Company is winding down two material agreements (Native Markets Temporary Use Agreement and Felix Foundation HAUS Agreement) involving approximately $28.7 million in combined asset value as of March 31, 2026. While this involves repositioning of assets rather than a traditional M&A transaction, covenant breach, or other specifically-defined event type, the termination of these material agreements and the return of ~800,000 HYPE tokens represents a significant strategic shift that would affect a reasonable investor's assessment of the Company's operations and asset positioning.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 3.03
The filing discloses a material modification to the rights of security holders, specifically relating to preferred stock rights, in connection with the transactions described in the 8-K.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 3.03
GPGI completed a reincorporation from Delaware to Nevada on June 5, 2026, materially modifying stockholder rights by changing the governing law and corporate charter. The reincorporation represents a significant corporate governance restructuring that affects the legal framework governing shareholder rights.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 3.03
The company effected a 1-for-20 reverse stock split on June 5, 2026, which was authorized by stockholders on April 29, 2026. This capital restructuring consolidates shares and adjusts exercise prices and share reserves, materially modifying the rights and economic interests of all security holders.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
Edesa Biotech disclosed favorable exploratory clinical data for paridiprubart showing a 32% relative reduction in 28-day mortality in AKI patients and a 23% relative reduction in MAKE30 incidence, presented at the ERA Congress. While this represents material clinical progress for a biotech company's lead candidate, the disclosure emphasizes these are exploratory, post-hoc analyses not prespecified in the statistical plan, with nominal p-values not adjusted for multiplicity and explicit caution that confirmatory studies would be required. This clinical milestone does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, restatement, or litigation), making it best classified as other_material given its potential significance to investors assessing the company's pipeline prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
A Special Committee is conducting an ongoing strategic review evaluating financing, recapitalization, restructuring, M&A, and other strategic transactions, with engagement of major financial advisors (Houlihan Lokey and FTI Consulting) and active discussions with lenders regarding potential credit agreement amendments.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
This disclosure announces translational pharmacometric modeling and initial Phase 1 safety data for CLYM116, an anti-APRIL monoclonal antibody candidate. The announcement includes positive preliminary safety findings (no serious adverse events, dose-limiting toxicities, or discontinuations in 49 healthy volunteers up to 320 mg) and supportive pharmacokinetic/pharmacodynamic modeling suggesting potential for less-frequent dosing. While this is a clinical development milestone for a pipeline asset, it does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation). The disclosure would be material to investors evaluating the company's pipeline progress and risk profile, particularly given the positive safety profile and advancement toward Phase 2 dosing in IgAN patients expected in Q3 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
The Board authorized an additional $370.0 million share repurchase authorization on June 3, 2026, bringing the aggregate authorization to $2.6 billion, signaling management's confidence in the stock's valuation and the company's financial position.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Dominion Energy entered into an underwriting agreement on June 3, 2026 for the sale of $825 million in senior notes due 2036. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories (it is not a dilutive equity issuance, M&A activity, or a financial covenant breach). The disclosure is material as it represents a significant financing transaction, but the taxonomy lacks a dedicated "debt issuance" category.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-06-05
Item 1.01
Goldman Sachs Real Estate Finance Trust renewed its advisory agreement with Goldman Sachs Asset Management, L.P. for an additional one-year period effective June 10, 2026, continuing the existing advisory relationship with no substantive changes to terms.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The company disclosed routine monthly distributions to shareholders and two significant loan originations totaling $186 million in new mortgage lending activity: a $53.0 million Durham Multifamily loan and a $133.0 million Chicago Multifamily loan, representing material operational activity for the real estate finance trust.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 8.01
Fortress Net Lease REIT declared distributions on May 29, 2026, with varying net distributions per share across six share classes ranging from $0.0547 to $0.0729 gross, affecting shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Universal Insurance Holdings amended its 5.625% Senior Unsecured Notes indenture on June 3, 2026, with majority noteholder consent. The amendments shorten the redemption notice period from 30 days to 5 days and permit conditional redemption notices, providing "greater operational flexibility" for redemption. While this is a material debt modification affecting the Company's $XXX million in outstanding notes, it does not fit cleanly into the covenant_breach or dilutive_issuance categories—it is a negotiated amendment to existing debt terms, not a breach or new issuance. The materiality stems from the modification of significant debt obligations and the Company's apparent intent to exercise redemption flexibility.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Falcon's Attractions (a subsidiary) entered into a Master Consulting Services Agreement valued at approximately $10.6 million to provide master plan design consulting services for a theme park in Arizona. While this is a material contract for a design consulting company, it does not fit neatly into the standard 8-K event taxonomy (not M&A, not an earnings release, not an executive change, etc.). The materiality threshold and revenue significance warrant disclosure, but the event is best classified as other_material given the absence of a more specific category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 3.03
Alphabet filed Certificates of Designations establishing Series A and Series B Preferred Stock with material rights modifications, including dividend restrictions on junior stock, mandatory conversion features with price-based conversion rates, and liquidation preferences that establish new senior securities with preferential rights.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Santander Holdings USA completed a public offering of $2.5 billion in aggregate principal amount of senior notes across three tranches (2030, 2032, and 2037 maturities). While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the more specific event categories (ma_activity applies to acquisitions/dispositions/mergers, not routine debt offerings; dilutive_issuance applies to equity securities, not debt). The disclosure is material but represents a financing event outside the standard taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 2.03
MSD Investment Corp. entered into Amendment No. 1 to its Senior Secured Credit Agreement, increasing the limitation on Shorter Term Unsecured Indebtedness from $200 million to $600 million, thereby expanding its borrowing capacity under the facility.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The disclosure announces a postponement of an extraordinary general meeting (EGM) from June 9 to June 12, 2026, to seek shareholder approval for extending the Company's initial business combination deadline from June 12, 2026 to June 12, 2027. While this involves a shareholder vote, the core event is the extension of the business combination deadline itself—a material corporate action for a SPAC that affects the timeline for completing its fundamental purpose. This does not fit cleanly into shareholder_vote_results (which typically reports vote outcomes, not the scheduling of future votes) nor into other specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-05
Item 2.03
The filing discloses creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, though the substantive details of the obligation are not fully provided in the available excerpts.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
Shareholders redeemed 7,167,225 Ordinary Shares at approximately $10.66 per share ($76.4 million aggregate), reducing outstanding shares from approximately 15.9 million to 8.75 million and leaving $46.2 million in the Trust Account, materially affecting the Company's capital structure and cash position.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The Sponsor distributed 2,781,776 Class B shares to its constituent members, including 478,010 shares each to CEO Paul Grinberg, CFO Douglas Horlick, and Director Jaime Vieser, representing a material change in share ownership and executive equity interests.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 5.03
Long Table Growth Corp. adopted an Amended and Restated Memorandum and Articles of Association effective June 3, 2026, in connection with the Company's IPO.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 7.01
BioCardia disclosed receipt of FDA meeting minutes confirming that its ongoing CardiAMP Heart Failure II Trial may support Premarket Approval (PMA) for the CardiAMP Cell Therapy System. This is a material regulatory milestone for a clinical-stage biotech company, as FDA confirmation of trial adequacy for PMA is a significant de-risking event that would affect investor assessment of the company's path to commercialization. However, this does not fit neatly into the standard taxonomy categories (not an earnings release, executive change, M&A, impairment, or other enumerated events), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 7.01
The disclosure announces results from an independent market landscape assessment for Annamycin in R/R AML, a clinical-stage asset. While this is material information about a key product candidate's competitive positioning, it does not fit cleanly into the standard taxonomy categories (not earnings, M&A, litigation, impairment, or other defined events). The assessment results could influence investor perception of the drug's commercial viability, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-05
Item 8.01
The filing discloses the Trust's first cash distribution of $351,669.96 from staking rewards and announces an ongoing monthly (or quarterly minimum) distribution policy. While this is a routine operational disclosure for an ETF, the announcement of the inaugural distribution and the establishment of a regular distribution schedule would be material to investors evaluating the Trust's income-generating characteristics and cash flow to shareholders. This does not fit neatly into earnings_release (which typically applies to operating company financial results) but represents a material distribution event specific to the Trust's staking operations.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 1.01
The disclosure describes entry into a "Remunerated Private Investment Agreement" involving a $1,000,000 capital deployment by Nomadar to Make A Mark Events SRL (owned by a company investor) with a 2.7% monthly return and 30-day repayment terms. While Item 1.01 typically covers M&A activity, this transaction appears to be a related-party investment or financing arrangement rather than a traditional acquisition or material disposition. The structure—a short-term, interest-bearing loan to an affiliate—does not fit cleanly into the M&A taxonomy but is material due to the significant capital commitment and related-party nature.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 8.01
The filing discloses preliminary assets under management (AUM) as of May 31, 2026, via press release. For an asset management company like Artisan Partners, AUM is a key operational metric that investors monitor closely to assess business performance and growth trends. While this is not a formal earnings release, the disclosure of material AUM figures would affect a reasonable investor's assessment of the company's business trajectory and is material to the total mix of information available.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-05
Item 1.01
Madison Air Solutions entered into a Seventh Amendment to its Credit Agreement on June 4, 2026, reducing the interest rate on its incremental term loan facility by 100 basis points from Term SOFR plus 2.75% to Term SOFR plus 1.75%, materially improving the registrant's financing costs.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-05
Item 3.03
Strive, Inc. disclosed material modifications to the rights of security holders through Certificates of Amendment to the Certificate of Designation for Variable Rate Series A Perpetual Preferred Stock (SATA Stock), increasing authorized shares to 40,000,000, which affects shareholder voting power and dilution risk.
View raw filing on EDGAR →